alpha defensins (NCI/NIH OTT)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namealpha defensins (NCI/NIH OTT)
Drug Alias Namedecanoyl-RVKR-chloromethyl ketone (NCI/NIH OTT)furin inhibitors (NCI/NIH OTT)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionFurin inhibitors
TargetsFurin
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A